126 related articles for article (PubMed ID: 9722208)
1. Effects of long-term administration of interferon alpha in two models of liver fibrosis in rats.
Fort J; Pilette C; Veal N; Oberti F; Gallois Y; Douay O; Rosenbaum J; Calès P
J Hepatol; 1998 Aug; 29(2):263-70. PubMed ID: 9722208
[TBL] [Abstract][Full Text] [Related]
2. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats.
Fort J; Oberti F; Pilette C; Veal N; Gallois Y; Douay O; Rousselet MC; Rosenbaum J; Calès P
Hepatology; 1998 Dec; 28(6):1525-31. PubMed ID: 9828216
[TBL] [Abstract][Full Text] [Related]
3. Long-term administration of PGE1 increases liver fibrosis and collateral blood flow in bile-duct-ligated rats.
Fort J; Pilette C; Oberti F; Veal N; Gallois Y; Douay O; Calès P
J Hepatol; 1999 Jan; 30(1):70-6. PubMed ID: 9927152
[TBL] [Abstract][Full Text] [Related]
4. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Oberti F; Pilette C; Rifflet H; Maïga MY; Moreau A; Gallois Y; Girault A; le Bouil A; Le Jeune JJ; Saumet JL; Feldmann G; Calès P
J Hepatol; 1997 Jun; 26(6):1363-71. PubMed ID: 9210625
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.
Croquet V; Moal F; Veal N; Wang J; Oberti F; Roux J; Vuillemin E; Gallois Y; Douay O; Chappard D; Calès P
J Hepatol; 2002 Dec; 37(6):773-80. PubMed ID: 12445418
[TBL] [Abstract][Full Text] [Related]
6. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis.
Matsuda Y; Matsumoto K; Yamada A; Ichida T; Asakura H; Komoriya Y; Nishiyama E; Nakamura T
Hepatology; 1997 Jul; 26(1):81-9. PubMed ID: 9214455
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats.
Dang SS; Wang BF; Cheng YA; Song P; Liu ZG; Li ZF
World J Gastroenterol; 2007 Jan; 13(4):557-63. PubMed ID: 17278221
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats.
Yao HW; Li J; Chen JQ; Xu SY
Acta Pharmacol Sin; 2004 Jul; 25(7):915-20. PubMed ID: 15210065
[TBL] [Abstract][Full Text] [Related]
9. Scutellaria baicalensis inhibits liver fibrosis induced by bile duct ligation or carbon tetrachloride in rats.
Nan JX; Park EJ; Kim YC; Ko G; Sohn DH
J Pharm Pharmacol; 2002 Apr; 54(4):555-63. PubMed ID: 11999134
[TBL] [Abstract][Full Text] [Related]
10. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats.
Boigk G; Stroedter L; Herbst H; Waldschmidt J; Riecken EO; Schuppan D
Hepatology; 1997 Sep; 26(3):643-9. PubMed ID: 9303494
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice.
Sugihara A; Tsujimura T; Fujita Y; Nakata Y; Terada N
J Hepatol; 1999 May; 30(5):859-67. PubMed ID: 10365813
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.
Moal F; Veal N; Vuillemin E; Barrière E; Wang J; Fizanne L; Oberti F; Douay O; Gallois Y; Bonnefont-Rousselot D; Rousselet MC; Calès P
World J Gastroenterol; 2006 Nov; 12(41):6639-45. PubMed ID: 17075977
[TBL] [Abstract][Full Text] [Related]
13. Animal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis.
Weng HL; Cai WM; Liu RH
World J Gastroenterol; 2001 Feb; 7(1):42-8. PubMed ID: 11819731
[TBL] [Abstract][Full Text] [Related]
14. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].
Kim MY; Baik SK; Jang YO; Suk KT; Kim JW; Kim HS; Cho MY; Choi SJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):159-67. PubMed ID: 18617763
[TBL] [Abstract][Full Text] [Related]
15. The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver.
Reichen J; Gerbes AL; Steiner MJ; Sägesser H; Clozel M
J Hepatol; 1998 Jun; 28(6):1020-30. PubMed ID: 9672179
[TBL] [Abstract][Full Text] [Related]
16. Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells.
Desmoulière A; Xu G; Costa AM; Yousef IM; Gabbiani G; Tuchweber B
J Hepatol; 1999 Apr; 30(4):621-31. PubMed ID: 10207803
[TBL] [Abstract][Full Text] [Related]
17. Bilioenteric anastomosis reverses hyperkinetic circulation in bile duct-ligated cirrhotic rats.
Jalink D; Urbanski SJ; Lee SS
J Hepatol; 1996 Dec; 25(6):924-31. PubMed ID: 9007722
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of salvianolic acid B on CCl(4)-induced hepatic fibrosis through regulating NF-κB/IκBα signaling.
Wang R; Yu XY; Guo ZY; Wang YJ; Wu Y; Yuan YF
J Ethnopharmacol; 2012 Dec; 144(3):592-8. PubMed ID: 23041223
[TBL] [Abstract][Full Text] [Related]
19. Improvement in liver fibrosis, functionality and hemodynamics in CCI4-cirrhotic rats after injection of the Liver Growth Factor.
Díaz-Gil JJ; Muñoz J; Albillos A; Rúa C; Machín C; García-Cañero R; Cereceda RM; Guijarro MC; Trilla C; Escartín P
J Hepatol; 1999 Jun; 30(6):1065-72. PubMed ID: 10406185
[TBL] [Abstract][Full Text] [Related]
20. [Curative effect of interferon-alpha on rat liver fibrosis induced by CCl4].
Yang HX; Yi YR
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):919-25. PubMed ID: 19001734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
